Table 2.
Sensitivity Analysis for Seroprevalence of Hepatitis B in Pregnant Women.
| Groups | No. of studies (no. of patients) | Prevalence | I2 |
|---|---|---|---|
| Overall | 43 studies (n = 267553) | 1.5% (1.3–1.7) | 96.1% |
| Age distribution | |||
| Less than 25 years | 14 studies (n = 16995) | 2.1% (1.4–2.8) | 94.1% |
| More than 25 years | 14 studies (n = 12243) | 1.6% (1.2–2.0) | 68.8% |
| Parity | |||
| Primipara | 8 studies (n = 18240) | 1.7% (1.0–2.4) | 94.9% |
| Multipara | 8 studies (n = 25443) | 1.4% (1.1–1.8) | 74.5% |
| Antenatal period | |||
| First trimester | 7 studies (n = 1645) | 1.8% (0.7–2.9) | 66.9% |
| Second trimester | 7 studies (n = 2629) | 3.0% (1.5–4.5) | 83.5% |
| Third trimester | 7 studies (n = 2994) | 2.3% (1.2–3.4) | 73.1% |
| Residence | |||
| Urban | 5 studies (n = 3220) | 1.3% (0.4–2.1) | 67.8% |
| Rural | 5 studies (n = 4063) | 1.4% (0.6–2.3) | 68.7% |
| Education | |||
| None or primary | 4 studies (n = 6562) | 3.8% (1.2–6.5) | 96.6% |
| Secondary or higher | 4 studies (n = 2912) | 1.5% (0.9–2.0) | 34.8% |